ORUKA THERAPEUTICS INC (ORKA:NASDAQ)
$59.58 -4.02 (-6.3208%)
Analysed ORUKA THERAPEUTICS INC (ORKA:NASDAQ) News Sources
This Startup’s Psoriasis Drug Studies Have Lifted Its Stock
10-04-2026
yahoo.com
Up Nearly 840% in a Year, Does This ‘Strong Buy’ Stock Have More Room to Run?
08-04-2026
barchart.com
Does Oruka’s Widening Loss and ESOP Shelf Registration Change The Bull Case For Oruka Therapeutics (ORKA)?
25-03-2026
yahoo.com
Does Oruka Therapeutics, Inc. (ORKA) Have the Potential to Rally 41.51% as Wall Street Analysts Expect?
17-03-2026
yahoo.com
Company News for Mar 16, 2026
16-03-2026
yahoo.com
VR Adviser Adds Over 1 Million Savara Shares
15-03-2026
fool.com
Oruka Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
12-03-2026
yahoo.com
Evaluating Oruka Therapeutics (ORKA) Valuation After Strong Recent Share Price Momentum
17-02-2026
yahoo.com
Oruka Therapeutics to Participate in Multiple Upcoming Conferences
09-02-2026
yahoo.com
Oruka Therapeutics Announces Positive Interim Phase 1 Data for ORKA-002 and Initiation of EVERLAST-B Trial of ORKA-001
12-01-2026
yahoo.com
What is the current price of ORUKA THERAPEUTICS INC (ORKA:NASDAQ)?
The current price of ORUKA THERAPEUTICS INC (ORKA:NASDAQ) is $59.58.
ORUKA THERAPEUTICS INC (ORKA:NASDAQ) absolute price change since previous trading day?
The absolute price change of ORUKA THERAPEUTICS INC (ORKA:NASDAQ) since the previous trading day is $-4.02.
ORUKA THERAPEUTICS INC (ORKA:NASDAQ) percentage price change since previous trading day?
The percentage price change of ORUKA THERAPEUTICS INC (ORKA:NASDAQ) since the previous trading day is -6.3208%.
What is the most recent average sentiment score for ORUKA THERAPEUTICS INC (ORKA:NASDAQ)?
The most recent average sentiment score for ORUKA THERAPEUTICS INC (ORKA:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for ORUKA THERAPEUTICS INC (ORKA:NASDAQ)?
The most recent sentiment for ORUKA THERAPEUTICS INC (ORKA:NASDAQ) is .
SEC-8K** Filing Available For ORUKA THERAPEUTICS INC (ORKA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.